The keratinocyte is a major cell type of the body, and in epidermis, keratinocytes have potential for future gene targeting and drug therapy. Despite the importance of keratinocytes in cell biology and medicine, little is known about the molecular mechanisms underlying keratinocyte-specific gene expression. Here, we report the first detailed characterization of the sequences and factors controlling expression of a human gene expressed specifically in keratinocytes. Using 5' upstream sequence of the human K14 keratin gene coupled to one of two reporter genes, we examined sequences necessary and sufficient for expression of K14 in both cultured human keratinocytes and in mitotically active basal keratinocytes of transgenic mouse epidermis. We demonstrated the existence of distal and proximal elements located 5' from the transcription initiation site of the hK14 gene, which when combined with a TATA box element, appear to act in concert to drive keratinocyte-specific expression. We examined the proximal region in detail. After using CAT assays to narrow a transcriptional activation element to within 110 bp, we demonstrated the existence of a keratinocyte nuclear factor which binds to a 10-bp palindrome, 5'-GCCTGCAGGC-3', within this domain. Using methylation interference analysis, we identified the G residues important for factor binding, and showed that point mutations in these G residues not only blocked factor binding but also resulted in decreased transcriptional activity of an hK14-CAT gene. The factor was most abundant in keratinocytes, was expressed at lower levels in some simple epithelial cell lines, and was not detected in fibroblasts or lymphoma cells. Moreover, the 10-bp sequence was similar to sequences found in the 5' upstream sequences of several other genes expressed in keratinocytes, and at least one of these genes, the human Kl gene, contained a sequence that competed with the hK14 proximal element for binding factor. Collectively, our data suggest that both the sequence and the nuclear factor that we have identified may be involved in controlling keratinocyte-specific expression in vitro and in vivo.
lomaviruses, although expression of human papillomavirus (HPV) genes has also been detected in relatively undifferentiated cervical carcinomas in vivo as well as simple epithelial-like cervical carcinoma cells in vitro (for review, see Broker and Botchan 1986) .
Despite minor differences, mitotically active keratinocytes from different stratified squamous epithelial tissues appear to be quite similar not only in morphology but also in biochemistry (Nelson and Sun 1983) . The major proteins expressed by these cells are a pair of keratins K5 (58 kD) and K14 (50 kD), which form the 10-nm cytoskeletal filaments (Nelson and Sun 1983; Eichner et al. 1986 ). In differentiating keratinocytes, the major proteins are also keratins; but in this case, the keratins are expressed in a tissue-specific fashion (for review, see Moll et al. 1982; Sun et al. 1984) .
For epidermis, terminally differentiating cells in vivo express
Cold Spring Harbor Laboratory Press on October 28, 2017 -Published by genesdev.cshlp.org Downloaded from keratins Kl (67 kD) and KIO (56.5 kD) (Fuchs and Green 1980; Moll et al. 1982; Roop et al. 1983) , and suprabasal cells in vitro express K6 (56 kD) and K16 (48 kD) (Sun et al. 1989) .
Little is known about the molecular mechanisms underlying the expression of genes in basal keratinocytes or the processes controlling changes in keratin and viral gene expression during keratinocyte differentiation. However, a number of recent studies have begun to focus on identifying putative regulatory domains and transcription factors that may be involved in expression of either endogenous or viral genes in keratinocytes (Marchuk et al. 1985; Blessing et al. 1987 Blessing et al. , 1989 Gripe et al. 1987; Hirochika et al. 1988; Ghin et al. 1989; Vassar et al. 1989; Jiang et al. 1990 ). For papillomaviruses, assessing the relevance to keratinocyte-specific gene expression has been complicated because (1) the viral genomes encode proteins that influence transcription of viral genes and (2) even though HPV genes are expressed preferentially in keratinocytes in vivo, most in vitro studies have been carried out with HeLa or G-33A cells, both of which appear to be relatively undifferentiated, simple epithelial-like cervical carcinoma cells that do not express most keratinocyte-specific structural proteins. Given this caveat, several HPV genes have been shown to contain sequences (defined to limits as small as -30-100 bp) that not only are required for viral expression but also bind epithelial-specific proteins (Gripe et al. 1987; Swift et al. 1987; Gius et al. 1988; Hirochika et al. 1988; Ghin et al. 1989 ). In contrast, for genes expressed naturally in keratinocytes, only coarsely defined regulatory domains (300 bp or greater) have been identified thus far (Blessing et al. 1989; Vassar et al. 1989; Jiang et al. 1990 ).
In the absence of molecular studies, the 5' upstream sequences of a number of genes expressed specifically in keratinocytes have been screened for similarities that may provide clues to sequences that may be important for gene expression (Johnson et al. 1985; Marchuk et al. 1985; Tyner et al. 1985; Blessing et al. 1987; Lersch et al. 1989) . From these comparisons, several putative regulatory sequences have been postulated on the basis of extensive similarities to known viral enhancer sequences (e.g., the SV40 core enhancer; Marchuk et al. 1985) , the widespread occurrence of a sequence (e.g., the GK 8-mer consensus sequence 5'-AANGGAAA-3'; Blessing et al. 1987; Gripe et al. 1987) , or the conservation of a sequence (e.g., 5'-TGGAGGTGTGA-3' among two closely related genes; Lersch et al. 1989) .
Because so little is known about the sequences and transcription factors involved in keratinocyte-specific expression, the extent to which such comparisons will prove to be valid is almost wholly unknown. The following questions are some that remain to be answered: Is there a common regulatory mechanism controlling expression of a large number of keratinocyte-specific genes? Are papillomavirus and keratinocyte genes regulated in similar fashions? Are the same transcription factors recruited to control gene expression in dividing and differentiating keratinocytes? Glearly, elucidating sequences necessary for keratinocyte-specific gene expression and purification of the proteins that interact with these sequences is a prerequisite to understanding transcription of genes in keratinocytes. To begin to investigate cell-type-specific expression in keratinocytes, we isolated and characterized the functional human genes encoding K14 (Marchuk et al. 1985) and K5 (Lersch et al. 1989 ). Not only do these genes encode the major keratinocyte proteins, but in embryogenesis, their expression is up-regulated coincident with the commitment of an embryonic basal cell to an epidermal fate (Kopan and Fuchs 1989) .
Previously, we reported that a human K14 gene construct containing -2300 bp of the 5' upstream sequence gave specific expression in the basal layers of stratified squamous epithelia in transgenic mice (Vassar et al. 1989) . In this paper we report results obtained from a series of experiments aimed at elucidating the sequences and factors involved in this keratinocyte-specific expression.
Results

Sequences sufficient for keratinocyte-specific expression of the human K14 gene reside in the 5'-upstream region
In the human genome, there are three K14 genes, but only one appears to be functional (Marchuk et al. 1985; Rosenberg et al. 1988) . To identify sequences involved in controlling K14 gene expression in keratinocytes, we first investigated whether there may be any important sequences 3' from the transcriptional initiation site. Because keratinocytes transfect with relatively poor efficiency (<1%), we resorted to an immunological assay to measure the amount of a modified K14 protein produced as a consequence of gene transfection. To distinguish the transgene product from endogenous K14, we added sequences encoding the carboxy-terminal antigenic portion of substance P (Albers and Fuchs 1987) . A hybrid K14 gene-modified cDNA was then prepared as described in Materials and methods and outlined in Figure  lA . Approximately 6000 bp of 5' K14 gene sequence was used to drive expression of the K14P gene, which contained the first five introns of seven present in the endogenous K14 gene (Marchuk et al. 1985) . The construct, referred to as pgK14P(-6000), also contained most of the 3'-noncoding sequence of the K14 mRNA and an additional 700 bp of K14 3' downstream sequence. Additional constructs were made that contained 2300 bp of 5' upstream K14 gene sequence coupled to K14P genes with either introns I-V, intron I, intron V, or no introns, as illustrated in Figure lA (for derivation of the constructs, see Materials and methods).
To examine expression of these constructs in keratinocytes, we transfected them into SGC-13 cells derived from a squamous cell carcinoma of the skin and known to retain K5 and K14 expression (Wu and Rheinwald 1981) . The transgene product was detected by immunoblot analysis of SDS-PAGE-resolved keratins using an Figure 1 . \A\ Genetic maps of pK14P(-2300) and derivatives. Constructions of pK14P(-2300) and derivatives are described in Materials and methods. Components are (from left to right): (thick black line) 5' upstream sequence of the human K14 gene (Marchuk et al. 1985) , extending from the translation initiation site ( + 64) to a restriction endonuclease or BAL-31 deletion site located at X kb 5' to this site, where for each plasmid, the distance X is indicated in nucleotides; (open box) complete coding sequence of human K14 cDNA, and for gene-cDNA hybrids, this region also contains up to 5 of the 7 introns of the human K14 gene (introns are indicated by internal, smaller black boxes); (stippled box) sequence coding for substance P tag (Albers and Fuchs 1987) ; (vertical striped box) K14 3'-untranslated sequence extending from 21 bp 3' to the TGA stop codon to the polyadenylation signal (pA); (diagonal striped box) K14 gene sequence extending ~700 bp 3' from pA. Restriction endonuclease sites: (R) £coRI; (H3) ffindlll; (A) Aval; (S) StuI; (R5) £coRV; (K) Kpnl; (Sc) SacR; (Bg) Bglll, (Sp) Sphl, (H) HaeU. Plasmid names: (p) pGEM plasmid; (g) any construct prepared w^ith a K14 gene-cDNA hybrid containing all K14 exons and the first 5 introns of the K14 gene; (K14P) the P-tagged K14; (I) any construct prepared Mrith a K14 gene-cDNA hybrid containing all K14 exons and only intron I; (V) any construct prepared with a K14 gene-cDNA hybrid containing all K14 exons and only intron I; (-X) the number of 5' upstream K14 nucleotides as described above.
(B) Expression of pK14P constructs in transiently transfected SCC-13 keratinocytes. SCC-13 cells were transiently transfected with pK14P constructs illustrated in A. At 90 hr posttransfection, cells were lysed and separated into soluble and insoluble fractions. The soluble fraction was removed for pgalactosidase assays to adjust samples for variation in transfection efficiencies, which ranged from 0.1 to 2.0%. IF proteins were isolated from the insoluble fraction and samples from equal numbers of transfected cells were resolved by SDS-PAGE and subjected to immunoblot analysis, as described in Materials and methods. The band detected with anti-P corresponded to the expected mobility of the K14P transgene protein and is indicated at left. Untransfected control cells and cells transfected with 5'-deletion constructs containing <2100 bp upstream sequence showed no K14P protein, even when immunoblots were overexposed for 4 days. Fvirthermore, a construct missing the 670-bp internal StuI fragment within the 2300-bp 5' upstream sequence retained its ability to express KI4P. anti-P antibody. The first six lanes of Figure IB illustrate the results of transfection analyses of these constructs. Whereas the anti-P antibody showed no cross-reactivity with any proteins from untransfected keratinocytes (lane 1), cells transfected with any of the five K14P constructs produced an IF protein with mobility slightly greater than 50 kD, as expected for the K14P protein (lanes 2-6). Cells transfected with pgK14P(-6000) produced somewhat lower levels of K14P than cells transfected with any of the constructs containing only 2300 bp of 5' upstream sequence. Although later experiments rendered the significance of this observation doubtful, its occurrence prompted us to use the -2300 5' fragment for sebsequent constructs. Despite occasional variability among repeated assays, cells transfected with any of the intron-containing constructs produced amounts of of K14P similar to that made by cells transfected with an intronless construct. Collectively, our data indicated that sequences within the first five introns did not appear to contribute appreciably to K14 gene expression. Additional evidence to support this conclusion is provided below.
Role of 5' upstream sequences in human K14 gene expression: preliminary evidence for the existence of a distal element
To examine the role of 5' upstream sequences, we used either the K14P intronless reporter gene or the K14P reporter gene with five introns and linked to them varying portions of the K14 5' upstream sequences, as shown in Figure lA . These constructs were then transfected into SCC-13 keratinocytes and assayed immunologically for K14P protein (Fig. IB) . Surprisingly, none of the constructs containing 1000 bp or less of 5' upstream sequence showed detectable K14P protein, as judged by immunoblot analysis (lanes 7-17). This was true whether introns were present (odd-numbered lanes) or, not (even-numbered lanes); and even when the immunoblots were overexposed, K14P expression was not detected. To see whether K14P was made in any of the cells transfected with the pK14P(^ -1000) constructs, we subjected transiently transfected cultures to immunofluorescence analysis using an anti-P antibody. Several positive cells could be detected from transfections of all constructs except pK14P(-l-1), missing the TATA box (data not shown). However, the number of cells showing detectable expression of K14P was -100 x less than that seen for cells transfected with the -2300 constructs. Interestingly, when sequences 450 bp 5' from the transcription initiation site were coupled with sequences sparming from 1120 to 2300 bp 5', gene expression was restored partially (lanes 18 and 19) . Thus, immunoblot analysis of IF preparations from cells transfected with pK14P(-2300AStu) or pgKI4P (-2300AStu) showed detectable levels of K14P, which on average were only about two to five times less than cells transfected with pK14(-2300) [see lanes 18-19, pKI4P (-2300AStu ) and pgK14 (-2300AStu) , respectively]. This observation suggested that within 1180 bp 5' upstream from the transcription initiation site, there is a distal regulatory element(s) necessary for KI4 gene expression.
Existence of a distal regulatory element in the human KM gene is confirmed by transgenic mice studies
To verify that the distal element in the human KI4 gene was a bona fide requirement for K14 gene expression, we introduced the purified genes from pK14P(-2300), pK14P (-450) , and pKI4P(-2300AStu) into the germ line of mouse embryos. Previously, we described in detail our analyses of six transgenic mice harboring the insert KI4P( -2300) (Vassar et al. 1989) . As judged by indirect antiP immunogold staining of tissue sections from transgenic offspring, every mouse tested that was transgenic for the K14P( -2300) construct expressed KI4P in stratified squamous epithelial tissues but not in other tissues (Vassar et al. 1989) . Figure 2 illustrates immunohistochemical anti-P staining of a section (5 jjim) of tail skin from a mouse transgenic with approximately one to two copies of the K14P(-2300) construct ( Fig. 2A) . As compared to a control (nontransgenic) mouse tail section (Fig. 2B) , the transgenic mouse tail showed primarily basal layer staining. In contrast to the easily detectable expression of K14P protein in K14P(-2300) transgenic mice, none of the seven different founder mice harboring 1-10 copies of the K14P(-450) gene showed detectable levels of K14P expression (see Fig. 2C , mouse tail skin from a mouse with 10 copies of the gene). Even though endogenous mouse K14 was readily detectable in these mice, transgene protein was not detected, as judged by both immunohistochemistry and immunoblot analysis. These data are consistent with our in vitro studies showing failure of pK14P ( -450) to give detectable levels of expression.
As further confirmation that K14 gene expression requires a distal element, a transgenic founder mouse with approximately one to two copies of K14P( -2300AStu) genes showed detectable levels of K14P in skin (see Fig.  2D for tail skin). However, although basal expression was seen in some portions of the tail skin (as shown in Fig. 2D ), some suprabasal cells also stained with anti-P (Fig. 2E ). Despite this somewhat aberrant staining pattern within epidermis, no staining was observed in dermis or in any other nonepidermal cells of the skin. Collectively, our transgenic data are in agreement with our in vitro studies and indicate that there are sequences distal to the TATA box and transcription initiation site of the K14 gene that are necessary for its expression in stratified squamous epithelia.
A more detailed analysis of the distal element in the human K14 gene
To conduct a more extensive and quantitative analysis of the K14 distal element, we improved the sensitivity of our assay by constructing a series of clones in which varying amounts of the 5' upstream sequences of the human K14 gene were used to drive expression of a reporter gene encoding chloramphenicol acetyltransferase Figure 2 . Tissue-specific expression of K14P in transgenic mice. Mouse embryos were microinjected with K14P genes purified from pK14P(-2300), containing the entire K14 5' upstream sequence; pK14P(-450), containing the proximal element only; or pK14P(-2300AStu), missing 670 bp of 5' upstream sequence but still containing the K14 proximal and distal elements (see Materials and methods). Transgenic mice were derived and assayed by Southern blot analyses to determine relative transgene copy number, as described by Vassar et al. (1989) . Six different founder mice were obtained for the K14P( -2300) construct, seven for the K14P(-450) construct, and one for the K14P( -2300AStu) construct. For all founder mice of a single construct, patterns of transgene expression were similar. Expression in founder mice was examined by immunoblot analysis of tail IF proteins (not shown) and immunohistochemistry of Bouin's fixed sections (5 |xm) of tail skin (shown). Tails (Marchuk et al. 1985) , extending from the transcription initiation site to a restriction endonuclease or BAL-31 deletion site located at X kb 5' to this site, where for each plasmid, the distance X is indicated in nucleotides; (open box) complete coding sequence of bacterial CAT cDNA; (diagonal striped box) SV40 3'-noncoding sequence, intron, and polyadenylation signal (Gorman et al. 1983) . Transcription initiation site is indicated by a wavy arrow. Restriction endonuclease sites: (R) £coRI; (H3) Hindlll; (A) Aval; (S) StuI; (R5) £coRV; (N) Nhel; (Bx) 5stXI; (E) exonuclease III; (B) 5su36I; (H) HaeW.
[A] The distal element. Each plasmid was cotransfected with a 3-galactosidase control gene into SCC-13 keratinocytes, and cell extracts were assayed subsequently for CAT expression and p-galactosidase activity as described in Materials and methods. CAT expression of each extract was normalized against the control and is shown as a percentage of pK14CAT( -2300). (B) The proximal element. Each plasmid was cotransfected with a p-galactosidase control gene into SCC-13 keratinocytes, and cell extracts were subsequently assayed for CAT expression and p-galactosidase activity as described above. CAT expression of each extract was normalized against the control and is shown as a percentage of pK14CAT( -2100).
(CAT) (Gorman et al. 1983 ). The 5' deletion clones used for transfection are shovs^n in Figure 3A .
When SCC-13 cells were cotransfected w^ith a control p-galactosidase plasmid and with pK14CAT constructs containing 2000-6000 bp of 5' upstream K14 gene sequence, all transfected cell extracts contained appreciable levels of CAT as measured by the immuno-sandwich ELISA assay (Fig. 3A) . When p-galactosidase assays were conducted to correct for variations in transfection efficiencies, it was apparent that within a factor of 3, the levels of CAT were similar for cells transfected with either pK14CAT(-6000), pK14CAT(-2300), pK14CAT (-2100), or pK14CAT(-2000) (see relative CAT levels given in Fig. 3A ). These data were in agreement with and extended our previous results obtained with K14P constructs.
As expected from our previous K14P studies, we detected only background levels of CAT when SCC-13 cells were transfected with pK14CAT( -1000) or with constructs containing larger 5' deletions. Moreover, even with cells transfected with a new construct containing 1400 bp of 5' upstream K14 gene sequence, CAT was not above background levels. With another new construct, pK14CAT(-1700), we detected CAT but at levels that were only -10% those of cells transfected with a construct containing an additional 300 bp of 5' upstream sequence. Collectively, our data indicate that within ~300-400 bp in a region spanning -1700 to -2100 5' upstream from the human K14 gene, there is a sequence that enhances CAT expression in keratinocytes.
Evidence for a major proximal element that acts cooperatively with the distal element to control expression of the human K14 gene
To determine whether any additional sequences are required in conjunction with the distal regulatory element, we conducted a series of 5' internal deletions progressing toward the TATA box and transcription initiation site of the K14 gene. To achieve a measurable CAT signal, sequences -2100 to either -1120 or -1000 were present in all constructs. The clones used for our initial CAT assays are shown in Figure 3B , along with the relative CAT levels obtained after SCC-13 keratinocytes were cotransfected with each construct and a p-galactosidase control plasmid. For this set of experiments, linear range CAT levels obtained with extracts from cells transfected with pK14CAT (-2100) were taken as 100%. As expected from our immunological results obtained with the pK14P(-2300AStu) construct, appreciable CAT levels (40 ± 15%) were obtained from extracts of cells transfected with pK14CAT(A-1120/ -450). However, because deletion of sequences between the two StuI sites consistently led to somewhat reduced reporter gene expression (either K14P or CAT), there may be a weak positive element(s) located between -450 and -1120 bp. When cells were transfected with pK14CAT(A-1120/-270) containing a larger internal deletion, the relative CAT levels obtained were often greater than those obtained with the parent construct. Hence, there may be a weak negative regulatory element between -450 and -270 bp. Whenever both sequences were deleted, e.g., in pK14CAT(A-1120/-270), transfection yielded SCC-13 extracts with close to wild-type K14CAT expression. A more detailed analysis of these sequences was not pursued.
Interestingly, removal of an additional 110 bp of K14 gene sequence, to create pK14CAT(A-1120/-160), produced a plasmid which, when transfected into SCC-13 keratinocytes, generated almost no CAT activity above background levels (Fig. 3B) . Further deletion to make pK14CAT(A-1120/-94) gave background levels of CAT. These data demonstrated the existence of a major proximal regulatory domain contributing to human K14 gene expression. Without the proximal domain located at -160 to -270, sequences encompassing the distal domain and the TATA box were not sufficient to drive expression of CAT in SCC-13 keratinocytes. Moreover, because constructs containing the proximal domain in the absence of the distal domain are also not able to drive CAT expression in SCC-13 cells (Fig. 3A) , these data suggest strongly that the proximal and distal domains act cooperatively to regulate K14 gene expression. A summary of these data is given in Figure 4 .
A protein in SCC-13 nuclear extracts binds to the proximal domain
We chose to focus on characterizing the proximal element further. We first completed the sequence from (-2100) . Any CAT value <2% was assumed to be below the levels of detectability of the assay and is entered as 2%. (Marchuk et al. 1985) and is indicated by the wavy arrow. Nucleotides are numbered, with this site assigned as -I-1, and the first nucleotide 5' from this site assigned as -1. Relevant restriction endonuclease sites: (Nh) Nhel; (Av) Aval; (Bs) Bsu36l} (Exo3) point of exonuclease III digestion on the A( -160) plasmid. Boundaries of the oligomers used for competition binding studies in Fig. 7 are marked by bars below the sequence, and the roman numerals denote the oligomer set number. The TATA box and two sequences described in the text are encased by stippled boxes. The open box denotes a perfect SPl consensus site (Wingender 1988 ).
-270 to the transcription initiation site (Fig. 5) . At -175 to -183 a sequence, 5'-AAGCCCAAA-3', was located, which was similar to a consensus 5'-AANC-CAAA-3' (often referred to as the CK 8-mer) recognized previously by Blessing et al. (1987) to be present in the 5' upstream region of a number of genes expressed primarily in keratinocytes.The sequence 5'-TGGGAAAG-3', which was similar to the SV40 core enhancer consensus 5'-GTGGAAAG-3', was located at -230 to -253 (see Marchuk et al. 1985) . However, the most striking aspect about the sequence within the proximal domain was that the sequence did not share 100% identity with any known regulatory consensus element identified thus far (Wingender 1988) .
To assess whether any of these sequences might be an important part of the proximal element and to determine whether the proximal and distal elements share a common regulatory sequence, we first examined the ability of the domain proximal to bind proteins isolated from human keratinocyte (SCC-13) nuclear extracts. Our DNA probe was a 176-bp Bsu36l-Nhel fragment, spanning the sequence -270 to -94 bp 5' upstream from the K14 transcription initiation site (Fig. 6A,  probe) . When radiolabeled double-stranded probe was combined with nuclear extract isolated from SCC-13 keratinocytes, a complex was produced that was resolved by nondenaturing acrylamide gel electrophoresis and showed significantly slower mobility than the probe itself (Fig. 6B , cf. first lane, probe alone, with second lane, probe and nuclear extract). Protein-DNA complex formation was not influenced by the presence of nonspecific competitor DNA, poly[d(I-C)] (Fig. 6B, all lanes) . binding activity of KERl. Protein-DNA complexes were obtained by combining 5 |xg SCC-13 nuclear extract ( ± protein as indicated over the gel lanes) with 10,000 cpm (-0.5 ng) radiolabeled DNA probe in the presence of an excess of nonspecific competitor (poly[d(I-C)]) or specific competitor (in this case, competitor 4, i.e., unlabeled probe DNA as indicated over the gel lanes), as described in Materials and methods. Complexes were resolved by electrophoresis through 5% polyacrylamide DNA gels (Maniatis et al. 1989) . Gels were exposed to X-ray film for 6 hr. KER-1 denotes radiolabeled probe band retarded as a consequence of interaction with a nuclear factor. Free denotes uncomplexed, probe. The radiolabeled probe-nuclear factor complex was eliminated by competition with unlabeled competitor 4 DNA. (C) Competition analysis of other K14 5' upstream sequences for the binding of KERl to the proximal element. Competitions were performed with a 100-fold molar excess of unlabeled competitor DNAs. Controls, (i.e., radiolabeled probe combined with nuclear extract, but in the absence of competitor DNA) are at both ends of the gel. The competitor used in each reaction is indicated over each lane.
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was greatly reduced by addition of a 100-fold molar excess of specific competitor DNA identical to the radiolabeled probe (Fig. 6B, last lane; Fig. 6C, competitor 4) . These data suggested that a nuclear factor present in SCC-13 nuclear extracts bound specifically to the K14 promoter, within the region of -270 and -94 bp 5' upstream from the transcription initiation site.
When the entire sequence from -I-1 to -2100 5' upstream of the human K14 gene was divided into five DNA fragments (for details, see Fig. 6A ) and used in 100-fold molar excess as competitors, only the unlabeled fragment containing the -270-to -94-bp sequence competed effectively for binding of probe to the major nuclear factor (Fig. 6C , cf. lane with competitor 4, i.e., unlabeled probe DNA, with lanes containing competitors 1, 2, 3, or 5). These data indicate that the nuclear factor bound specifically to the DNA fragment encompassing the proximal domain but did not bind effectively to DNA fragments encompassing other 5' upstream K14 sequences, including the DNA fragment encompassing the distal domain. Collectively, the results suggest that if the distal domain binds the same factor as the proximal domain, it probably does so with a weaker association constant.
The major band seen in the gel mobility-shift assays was the only one that was reduced dramatically as a consequence of 100-fold molar excess of unlabeled probe. We have tenatively assigned the protein(s) involved in this complex the name KERl. Several minor bands were also detected in the gel mobility-shift assays ( Fig. 6B and C) . One band, which migrated at slightly slower mobility, persisted when the assay was conducted in the presence of unlabeled competitor probe (lanes with competitor 4), indicating that this band likely originated from nonspecific protein-DNA intertions. Several bands, which migrated at slightly faster mobility than the major band, were not seen with fresh preparations of nuclear extract and probably represent degradation products of the KERl protein.
Localization of the binding site for the keiatinocyte nuclear factor KERl
To localize further the DNA sequence involved in KERl binding, we repeated our mobility-shift assays, this time using annealed (i.e., double-stranded) synthetic oligomers as unlabeled competitors. Our six sets of complementary oligomers spanned the length of the 176-bp Bsu36l-Nhel probe, and each set overlapped the next in sequence by 15 nucleotides (see Fig. 7, top) . Only the set of oligomers spanning region II (-195 to -240) competed quantitatively for binding of KERl to the 176-bp radiolabeled probe (Fig. 7, bottom, competitor II) . The set of oligomers spanning region III (-165 to -210) seemed to show some competition for binding in this experiment, but this was not seen consistently. Collectively, our data indicate that the keratinocyte nuclear factor KERl binds to a sequence located within region II. The sequences in oligomer set II were entirely within the sequence extending from -160 to -270, that is, the sequences shown by CAT assays to constitute the proximal domain necessary for expression of the human K14 gene.
KERl binds to a specific sequence in both the K14 and the Kl genes and is involved in K14 gene expression
Methylation interference analysis (Ausubel et al. 1989 ) was used to localize G nucleotides on either strand of the 176-bp Bsu36l-Nhel fragment (-270 to -94) that closely interact with KERl. As shown in Figure 8 for the coding strand (left), methylation of G residues at positions -231, -224, and -223 (denoted by solid arrowheads) resulted in interference with KERl binding, whereas methylation of a G residue at position -227 (open arrowhead) showed weaker interference. Similarly, for the noncoding strand, methylation of G residues at positions -230 and -229 interfered with KERl binding, whereas a methylated G residue at position -226 showed weaker interference (Fig. 8, right) . These data suggested that residues -231 to -222 (encased by a stippled box in Fig. 5 ) may be involved in KERl binding.
To test the validity of the sequences we identified in our methylation interference assays and to characterize further the KERl-binding site, we prepared a 47-bp double-stranded oligomer with a scrambled 9-bp sequence extending from -231 to -223 in the K14 gene. As expected, this mutant oligomer (competitor 2) failed to compete for binding of KERl to the radiolabeled Bsu361-Nhel fragment (Fig. 9, lane 2) . Three additional double-stranded oligomers, with single point mutations in nucleotides -231, -230, and -229, respectively, were also unable to compete for KERl binding (lanes 3-5). Conversely, a double-stranded oligomer with 4 bp mutated outside the putative binding sequence competed effectively for KERl binding (lane 6). These results confirmed and extended our methylation interference data and indicate that the KERl binding site is the sequence 5'-GCCTGCAGGC-3'. Interestingly, this sequence is a perfect palindrome.
The KERl-binding site was adjacent to a 7-bp sequence 5'-CACACCT-3' (shown encased in a stippled box in Fig. 5 ) with 100% sequence identity to a sequence found in the E6/E7 promoter element of HPV 11 (Chin et al. 1989 ). Because a simple epithelial factor, CEII, was shown to bind in the vicinity of this HPV sequence (Chin et al. 1989) , we wanted to make certain that KERl and its binding site were distinct from CEII and its site. Using gel mobility-shift assays, we showed that mutation of this 7-mer sequence in the K14 gene did not interfere with the ability of a double stranded 45-mer 5' TGCCAACAACACACCTGGCGCCAGGGCGCGGTATTGC 3' -195 TGGCGGGACAAGAAAGCCCAAAACACTCCAAACAATG -159 -13 8 CGTAAAAATCTTGTA'rEGCTGCAG"5ClAAGCCAAACCCTTGAC -9 6 C 1 2 3 4 5 C 6 7 8 C 9 Figure 9 . Mutational analysis of the KERl-binding site.
[Top] Sequences of oligomer sets chosen for more specific competition studies. The boxed sequence represents the putative KERl-binding site. The underlined sequences refer to these of interest, as discussed in the text. Mutated nucleotides are in boldface type. The K14 CK 8-mer-like sequence is not a perfect match with the consensus described by Blessing et al. (1987) . The K14 wt oligomer corresponds to the wildtype sequence of the proximal element as shown in Fig. 5 . CEII corresponds to a 38-bp sequence of 11 involved in cell-specific expression of HPV 11 in a cervical carcinoma line C-33A (Chin et al. 1989 ). The underlined sequence shares 100% identity with the underlined sequence in oligomer K14 wt. [Bottom] Competition binding studies conducted with the annealed oligomers shown above. Studies were conducted as described in the legend to (competitor 6) to compete for binding to KERl (Fig. 9,  lane 6) . Similarly, the corresponding HPV 11 sequence (competitor 7) did not block binding of KERl to the wild-type K14 sequence (lane 7). These data confirm that the KERl factor is distinct from the CEII factor. As a final control, we also showed that the sequence similar to the CK 8-mer, the element found in the 5' upstream region of a number of keratinocyte-specific genes, did not compete for KERl binding (Fig. 9, lane 8) .
The sequence 5'-GCCTGCAGGC-3' was found only once within the 270-bp proximal domain of the K14 gene. However, the sequence 5'-GCCNNNNGGN-3' corresponding to the G nucleotides identified by methylation interference assays, was found three times within this domain. To determine whether this sequence was sufficient to compete for KERl binding, we tested the ability of a 45-bp synthetic oligomer, centered about the sequence 5'-GCCTGTGGG-3' (-91 to -83), to compete with the intact proximal region segment. Competition was not detected at > 100-fold excess (not shown). Hence, residues in addition to those identified by methylation interference must be essential for KERl binding.
When we searched the 5' upstream sequences of several human keratinocyte genes, several interesting comparisons were found. Although 6-bp stretches with 100% identity were foimd 5' from the involucrin gene (Eckert and Green 1986) and the K6b gene (Tyner et al. 1985) , a sequence identical in 9 of 10 bp to the KERlbinding site, e.g., 5'-GGCTGCAGGC-3', was found just 5' from the TATA box in the gene encoding Kl, a differentiation-specific gene (Johnson et al. 1985) . Interestingly, an oligomer corresponding to the wild-type Kl sequence showed competition for KERl binding (Fig. 9,  lane 9 ). This result demonstrated that KERl binds to at least one other mammalian epidermal keratin gene and suggested the intriguing possibility that the factor may be important in regulating other keratinocyte genes. some of which are expressed in differentiating keratinocytes.
To determine whether the KERl-binding site played a functional role in CAT expression, we conducted site-directed mutagenesis on pK14CAT(A-1120/-270) to engineer a single mutation at residue -230 (C-^ A). This mutation was chosen because it eliminated competition for KERl binding (see Fig. 9 ). When the point mutant, pK14CAT (A-1120/-270 mut -230) was introduced into SCC-13 cells, the level of CAT expression was reduced to 44% of the wild-type levels (Table 1) , thus demonstrating functionality.
KERl appears to be more abundant in keiatinocytes than in fibroblasts or in some simple epithelial cell types
To determine whether active KERl is generated by nonkeratinocyte cell types, we isolated nuclear extracts from a variety of human cell types: SCC-13, a squamous cell carcinoma cell line of epidermal origin (K14+ + ), dip- Fragments inserted into a CAT expression plasmid were transfected into SCC-13 cells and assayed for CAT expression (see Materials and methods). Mutations were generated by the polymerase chain reaction, and were sequenced to verify their identity (Ausubel et al. 1989 ). CAT expression is indicated as a percentage of pK14CAT(-2300). The mut-230 value represents the average of two separate experiments.
loid WI-38 fibroblasts (K14--), HeLa, a cervical adenocarcinoma cell line (K14"-), MCF-7, a mammary adenocarcinoma cell line (KU"-), and Jurkat, a T-cell lymphoma cell line (K14--). Relative KERl-binding activity was then measured by combining equal amounts of nuclear protein from each cell type with radiolabeled proximal element as probe and repeating the gel mobilityshift assays as before. The results of our experiments are shown in Figure 10 . As judged by this assay, keratinocytes appeared to produce higher levels of KERl (lane 1) than any of the nonkeratinocyte lines (lanes 2-5). Whereas fibroblast (lane 2) and lymphoma extracts (lane 5) showed little or no nuclear-binding activity, MCF-7 extracts showed some binding (lane 4), and HeLa extracts showed appreciable binding (lane 3). This finding may explain why we have observed substantial promiscuous expression of our pK14P and pK14CAT constructs in HeLa cells (Vassar et al. 1989; A. Leask, M. Rosenberg, and E. Fuchs, unpubl.) . At present, we have not determined why the endogenous K14 gene is not transcribed in HeLa , nor do we know whether the observed tissue-specific differences in factor binding reflect differences in relative levels of KERl (or a KERl-like protein) or, alternatively, tissuespecific differences in the binding capacity of KERl. Future studies will be necessary to answer these questions and also to ascertain whether KERl expression is altered during keratinocyte differentiation.
lu M
Wm^- Figure 10 . Tissue specificity of KERl binding activity. Nuclear extracts were isolated from different human cultured cell lines, including SCC-13 cells from an epidermal squamous cell carcinoma (K14+), WI-38 diploid fibroblasts (K14-), HeLa cells from a cervical adenocarcinoma (K14-), MCF-7 cells from a mammary adenocarcinoma (K14"), and Jurkat lymphoma cells (K14-). Total nuclear protein was measured (Bradford 1976) , and equal amounts (5 | xg) from each cell line were combined with 10,000 cpm (-0.5 ng) of ^^P-labeled probe corresponding to the complete proximal element encompassing K14 nucleotides -270 to -94. Complexes were resolved and analyzed as indicated in the legend to 
Discussion
The pioximal element: an epithelial-specific element
Our studies revealed the importance of a sequence, 5'-GCCTGCAGGC-3', contained within a 110-bp proximal domain 5' from the transcription initiation site of the human K14 gene. That this 10-nucleotide motif may be important in regulating keratinocyte gene expression is underscored by the fact that point mutations restrict expression of a reporter CAT gene in transfected keratinocytes and that this sequence is the site for the binding of a nuclear factor, KERl, which is more abundant in cultured keratinocytes than it is in fibroblasts or in some simple epithelial cell lines. Our additional finding that a 45-bp sequence in the human Kl gene competes for KERl binding suggests that KERl may be involved in the expression of more than one keratinocyte gene. While this paper was out for review, Snape et al. (1990) reported the characterization of the binding of a Xenopus embryo nuclear factor (KTF-1) to a Xenopus keratin gene expressed specifically at mid-blastula transition in the outer ectoderm. Gel mobility-shift and methylation interference assays identified the KTF-1-binding sequence as 5'-ACCCTGAGGCT-3', and multiple copies of this sequence linked to a reporter gene resulted in enhancement, albeit nontissue specific, of gene expression. With a 1-nucleotide gap, this Xenopus sequence shared a 10-nucleotide sequence (of 11) identity with the KERl-binding site, prompting us to examine whether the Xenopus and human nuclear factors might be evolutionarily related. Despite the striking sequence similarities between the Xenopus and human sites, we were unable to demonstrate efficient competition by a 30-bp oligomer containing the Xenopus sequence (corresponding to "C" in Snape et al. 1990 ) for binding of KERl to the human K14 proximal element.
The last 5 residues of the consensus AP2-binding site, 5'-CCCCAGGC-3' (Williams et al. 1988) , are identical to half the KERl palindrome. We have shown that a 26-bp oligomer containing an AP2 site competes for KERl binding to the proximal element, suggesting that KERl may be AP2 or an AP2-like factor. Since a perfect AP2 site is also upstream from the human K5 gene, AP2 could be generally involved in keratinocyte gene expression. Studies are under way to test this hypothesis.
The distal region: synergistic effects between two regulatory regions within the human K14 keratin gene
We have not yet elucidated the sequences constituting the distal element nor have we identified the nuclear factors that might interact with these sequences. However, in preliminary competition experiments, we were unable to demonstrate competition of a fragment containing the distal element for the binding of KERl to the radiolabeled proximal element. Although unequivocal demonstration must await elucidation of the precise regulatory sequences of the distal element and the protein that binds to this element, these simplistic data are already suggestive that the two elements may be distinct.
The interdependency of the distal and proximal regions of the human K14 gene was particularly strong: Neither region alone was sufficient to drive expression of a reporter gene coupled to a TATA box and ~75 additional 5' upstream K14 gene sequence; whereas the two regions combined gave marked expression. The most likely interpretation of these data is that the proximal and distal elements and their respective binding proteins act combinatorially with the TATA box and TFIID to create a stable transcription complex. Such synergism has also been reported recently for several promoters, including Drosophila homeo box elements (e.g., see Han et al. 1989 ) and the a-skeletal actin regulatory elements (Muscat and Kedes 1987; Gustafson et al. 1988) .
It is interesting to note that the Xenopus keratin gene element, binding KTF-1 and sharing homologies with the KERl element, was unable to act in single copy to up-regulate expression of a reporter gene (Snape et al. 1990 ). Moreover, in multiple copies, the KTF-1 element was unable to confer epidermis-specific gene expression, suggesting that other factors in addition to KTF-1 may also be involved in producing high levels of epidermisspecific expression (Snape et al. 1990) . As the relation between keratin gene expression in Xenopus embryonic ectoderm and adult human epidermis is explored more deeply, and as other keratinocyte genes are analyzed, the extent to which complex and cooperative regulatory elements are generally utilized in keratinocyte-specific gene expression should become clearer.
Regulation of the human K14 gene: possible clues to mechanisms for differentiation-specific keratinocyte expression}
Little is known about the mechanisms controlling the differentiation-specific changes in gene expression patterns in keratinocytes. However, our finding that a sequence that binds KERl is also found 5' upstream from a human Kl gene is suggestive that at least some regulatory elements found in basal keratinocyte genes may be shared among differentiation-specific keratinocyte genes. Whether changes in gene expression during keratinocyte differentiation are controlled predominantly by transcription factors that may be modified differentially during the keratinization process or whether transcriptional changes take place via differential expression of new regulatory factors remains to be determined. As we learn more about the distal element involved in K14 gene expression, and as we explore further the role of proximal element factor KERl in the expression of K14 and other keratinocyte-specific genes, we hope to unravel some of these remaining mysteries underlying the changes in gene expression during terminal differentiation.
Materials and methods
Construction of recombinant clones
pK14P (-2300) and derivatives Clone pK14P(-2300) was referred to previously as pH3cK14 • P (Vassar et al. 1989) . In order, it contains -2300 bp of sequence 5' to the K14 transcriptional initiation site (Marchuk et al. 1985) ; the 5'-untranslated sequence of the K14 gene; the complete human K14 coding sequence except for sequences encoding the 5 carboxy-terminal amino acid residues, which were replaced with sequences encoding the antigenic portion of a neuropeptide substance P (Albers and Fuchs 1987) ; a TGA translation stop codon; and K14 genomic sequences including the 3'-untranslated sequences, polyadenylation signal, and -700 bp of 3' downstream sequence. This insert was cloned into the HirzdIII-EcoRI sites of plasmid pGEM2 (Promega) as described by Vassar et al. (1989) .
To make 5' deletions of the parent clone pK14P( -2300), convenient restriction endonuclease sites located in the 2300-bp 5' upstream sequence were used in conjunction with the unique £coRI site at the 3' end of the K14 genomic sequences. K14P inserts were created by double digestions with £coRI and either £coRV, Stul, Haell, or Aval, as shown in Figure lA , and the inserts were cloned into multiple cloning regions of appropriate pGEM plasmids. This resulted in pK14P( -1000), pK14P( -450), pK14P (-94) , and pK14( + l), respectively. To make pK14P (-6000), the 6400-bp EcoRl-Kpnl fragment was isolated from the 5' end of genomic clone GK-1 (Marchuk et al. 1985) , ligated to the 1800-bp KpnI-EcoRl 3' fragment from pK14P(-2300), and inserted into the £coRI site of pBluescript KS-l-(Stratagene). pK14P (-245) and pK14P (-202) were made by limited BAL-31 exonuclease digestion of pK14P(-450), followed by digestion with £coRI and ligation of the resulting K14P fragment into pGEM2. Finally, pK14P(-2300AStu) was created by digesting pK14P(-2300) with Stul and religating the large fragment.
pgK14P(-2300) and intron-containing derivatives
To create pgK14P(-2300) containing introns 1-5 from the K14 gene, pK14P( -2300) was digested partially with Sphl and completely with Kpnl. This KpnI-SphI fragment containing K14 cDNA sequence from exon 1-exon 6 was replaced by the corresponding Kpnl-Sphl sequence from genomic subclone pJgK14 (Giudice and Fuchs 1987) . The Kpnl-EcoRl fragment from pgK14P (-2300) containing coding sequences, introns, and 3'-flanking region, was used to replace the corresponding Kpnl-EcoRl fragment from pK14P(-X) clones to create the respective intron-containing clones: pgK14P(-450), pgK14P(-245), pgK14P (-202), pgK14P(-94) , pgK14P( + l), and pgK14P (-2300AStu). pgK14P( -6000) was made by hgating the EcoRIKpnl 5' K14 fragment from pK14P(-6000) with the KpnlEcoRl 3' K14 fragment from pgK14P(-2300) and inserting them into the £coRI site of pGEM3Z. pK14PI( -2300) was made by replacing the 138-bp Kpnl-Sacll fragment from pK14P (-2300) with the 1400-bp Kpnl-Sacll fragment from pgK14P (-2300), which contains intron I. pK14PV( -2300) was created by replacing the 967-bp Bglll fragment from pK14P(-2300) with the 1062-bp fragment from pgK14P(-2300), which contains intron V.
K14CAT expression vectors: distal constructs
To facilitate future cloning steps, the 55-bp Hi22dIIl-£coRI fragment from pGEM3 containing the multiple cloning region was ligated into the Hindlll site of pSVOCAT (Gorman et al. 1982) to create pSVOCAT'PLl. Incompatible 5'-or 3'-extended ends created by restriction enzyme digestion of all DNAs were made blunt with Escherichia coli polymerase Klenow fragment (5' ends) or T4 DNA polymerase (3' ends). pK14CAT(-2100) was created by inserting the 2100-bp Aval fragment from pK14P(-2300) into the Aval site of pSVOCAT-PLl. pK14CAT(-2300) was made by replacing the 1800-bp Xbal-Bsu36l fragment from pK14CAT(-2100) with the 2000-bp Hindlll-Bsu36l fragment from pK14P(-2300). To create pK14CAT(-6000), the 1300-bp Xbal-EcoKV fragment from pK14CAT(-2100) was replaced with the 4700-bp EcoRl-EcoKV fragment from pK14P(-6000). The 1000-bp EcoRY-Aval fragment from pK14P(-2300) was hgated into the Xbal-Aval sites of pSVOCAT • PLl to form pK14CAT(-1000). pK14CAT(-450), pK14CAT(-270), and pK14CATi-94) were made by digesting pK14CAT(-2100) with Stul and Xbal, Bsu36l and Xbal, or Nhel and Xbal, respectively, and then religating. Finally, to create pK14CAT ( -2000) , pK14CAT(-1700), and pK14CAT(-1400), pK14P(-2300) was digested with BAL-31 exonuclease followed by digestion with Aval. The BAL-31-Aval fragments were then ligated into the Xbal-Aval sites of pSVOCAT -PLl.
K14CAT expression vectors: proximal constructs
The parental construct for proximal deletion plasmids was pK14CAT(-2100). This plasmid was generated by subcloning the 2100-bp Aval-Aval fragment of the K14 promoter region into the Hindlll site of pSVOCAT after blimt ends were created with Klenow fragment. Most internal deletions were made by employing endogenous restriction sites. The other deletions were made first by subcloning the EcoKV-Ncol fragment of pK14CAT(-2100) into the multiple cloning region of pGEM5 (Promega). The resultant subclone was then cut at the BstXL site immediately upstream of the insert (leaving a protected 3' overhang) and at Bsu361 or £coRV in the insert. Exonuclease III and mung bean nuclease were then used to generate deletions as described by the manufacturer (New England Biolabs). The junctions of the deletion constructs made with this method were sequenced and then subcloned into pK14CAT(-2100). Point mutations of pK14CAT(A-1120/-270) were introduced using mutant oligomer hybridization and polymerase chain reactions (PCRs) to generate the appropriate mutant fragments, and then replacing the wild-type fragment with the mutant one by subcloning. In all cases, fragments generated by PCR were sequenced to confirm their identity.
Cells and transfections
The human lung fibroblast line WI-38 (ATCC, Rockville, MD) and human breast adenocarcinoma line MCF-7 (ATCC) were cultured in a 3 : 1 mixture of Dulbecco's modified Eagle medium and Ham's F12 medium, supplemented with 10% newbom calf serum. The simple epithelial human cervical carcinoma line HeLa (ATCC) was cultured in the same medium supplemented with 10% fetal calf serum. Human SCC-13 squamous cell carcinoma cells, obtained as a gift from Dr. James G. Rheinwald (Wu and Rheinwald 1981) , were grown in the same medium, supplemented with 10% fetal calf serum, 10"^° M cholera toxin, 10"" M insulin, 2 x 10"^° M triiodothyronine, and 5 M-g/ml human transferin (Rheinwald and Green 1977) .
Plasmid DNAs were purified by CsCl density gradient centrifugation, as described in Glover (1985) . For all transfections, an equal number of SCC-13 keratinocytes were seeded on 100-mm dishes and transfected 2 days after plating. Plasmid DNAs used for transfections were 6 x 10"^^ moles of K14P or CAT expression plasmids, 1.2 x 10"'^ moles of pCHllO (Hall et al. 1983) , and variable amounts of carrier DNA (pKS + ; Stratagene) to equalize the total amount of DNA to ~45 ji.g/transfection. Transfections were carried out by use of the calcium phosphate method (Graham and Van der Eb 1973) , followed by a 15% glycerol shock (Parker and Stark 1979) . Cells were harvested 65-90 hr post-transfection for either immunoblot or CAT analysis, and for p-galactosidase analysis.
Intermediate filament protein extraction and immunoblot analysis
Intermediate filament proteins were isolated according to Wu et. al. (1982) . The supernatant was removed and frozen (-70°C) for subsequent analysis of p-galactosidase activity. Protein concentrations were determined by the method of Bradford (1976) . IF proteins isolated from equal numbers of transfected cells were resolved by use of SDS-PAGE, followed by electrophoretic transfer to nitrocellulose plus paper (Micron Separations, Schiller Park, IL) for immunoblot analysis, which was performed as described previously (Albers and Fuchs 1987) . The blot was exposed to X-ray film for 18 hr. The relative levels of the substance P-tagged transfected gene product were then estimated by densitometry scanning of autoradiographs.
Preparation of transgenic mice and immunohistochemistry of tissue sections
DNA inserts from pKI4P(-2300), pKI4P(-450), and pK14P (-2300AStu) were excised, purified, and microinjected into male pronuclei of single cell embryos from an outbred strain (CD-I) of mice (Charles River Laboratories) as described previously (Vassar et al. 1989) . Mouse tail DNAs were assayed by Southern blot analysis for the presence of human K14P sequences, and gene copy number was estimated (see Vassar et al. 1989) . A small piece (-0.25 cm) of tail skin was removed from each transgenic founder mouse, fixed in Bouin's solution, and sectioned (5 |jim) for immunohistochemistry. The sensitive immunogold enhancement procedure was utilized as described by the manufacturer (Janssen Pharmaceuticals, Piscataway, NJ). The NCI/34 anti-P antibody was used to detect the K14P transgene product (Accurate, Westbury, NY).
Cell extracts, fi-galactosidase assays, and CAT assays
Cell extracts were made according to Gorman et al. (1983) , and total protein was measured by use of the Bradford method (1976) . CAT protein was measured by use of the colorimetric sandwich ELISA method as outlined by the manufacturer (5 Prime -^ 3 Prime, Inc., Westchester, PA). Briefly, for each sample, equal amounts of protein extract in a total volume of 200 |xl of dilution buffer were added to a microliter plate well coated with an anti-CAT antibody. After incubation to allow CAT enzyme to bind and washing steps to reduce nonspecific binding, biotinylated anti-CAT antibodies (which detected the bound CAT-antibody complex) were added. To quantitate the amount of biotinylated anti-CAT antibodies bound to each microliter well, alkaline phosphatase-conjugated streptavidin was added; and following incubation and washing, p-nitrophenyl phosphate substrate was added. After exactly 30 min, the reaction was terminated with NaOH. The resultant color change was then measured at 405 nm with a microliter plate reader (Molecular Devices, Palo Alto, CA). The amount of CAT protein in each extract was estimated by a standard curve generated by assaying a number of standard samples containing various dilutions of purified CAT protein. For each extract, the number of picograms of CAT protein per microgram of total protein was determined. CAT activity values were compared with samples of extracts from transfections with pSVOCAT, which lacks eukaryotic promoter sequences and thus serves as a baseline indicator of CAT activity, and pK14CAT(-2300) or pK14CAT( -2100), as indicated, which were taken to represent 100%. Under these conditions, pSV2CAT, containing the SV40 promoter and enhancer (Gorman et al. 1982 (Gorman et al. , 1983 , showed an expression level of -300%.
When two or more extracts were compared, the transfection efficiency of the plasmids was accounted for by comparing the p-galactosidase activities of the extracts and normalizing the CAT values accordingly. The enzymatic assay for p-galactosiCold Spring Harbor Laboratory Press on October 28, 2017 -Published by genesdev.cshlp.org Downloaded from Regulation of a human keratinocyte-specific gene dase was measured spectrophotometrically following the method described in Glover (1985) .
For both CAT and 3-galactosidase, all assays were performed within the linear range.
Nuclear extracts and mobility-shift assays
Nuclear extracts were prepared by the method of Dignam et al. (1983) , as modified by Lee et al. (1988) . Phenylmethylsulfonyl fluoride (PMSF) was added to 2 mM in all solutions. Protein concentrations were measured according to Bradford (1976) .
For nuclear extract binding studies, double-stranded DNA fragments were generated with appropriate restriction endonucleases and resolved by agarose gel electrophoresis. Fragments were recovered by electrophoretic transfer onto DEAE NA45 nitrocellulose (Schleicher &i Schuell, Keene, NH), followed by visualization of the transferred DNA bands with brief ethidium bromide staining (1 |xg/ml) and incubating the filter section containing the desired DNA fragment in the presence of 20 mM Tris, 1 mM EDTA, 1 M NaCl (pH 8.0) for 30 min at 68°C.
Fragments to be used for probe were radiolabeled by use of the Klenow fragment and [a-32p]dCTP (Maniatis et al. 1989 ). Fragments to be used for competitor were generated either by restriction endonuclease digestion of the K14 5' upstream region and purification as described above, or oligonucleotide synthesis of both strands of a 30-to 46-bp sequence. Oligonucleotides were synthesized by use of a 3 SOB DNA synthesizer (Applied Biosystems, Foster City, CA). Complementary strands were annealed and purified from single-stranded DNAs by gel electrophoresis through 3% Nusieve, 1% Seakem agarose gels (FMC Corporation, Rockland, MD). DNA fragments were recovered by use of DEAE NA45 paper as described above.
Gel mobility-shift assays were conducted essentially as described by Fried and Crothers (1981) . For each reaction, a nuclear extract mixture was prepared, which contained 5 |xg of nuclear extract, 5 |xg of BSA, and 2 |xg of poly[d(I-C)] (Boeringer Mannheim) in 12% glycerol, 20 mM HEPES-KOH, 75 mM KCl, 2 mM DTT, 2.5 mM MgCli, and 1 mM EDTA (pH 7.9). After a 5-min preincubation of the mixture on ice, 10,000 cpm (0.5-1.0 ng) of radiolabeled probe and (wherever appropriate) a 100-fold molar excess of unlabeled competitor DNA were added to the mixture. The mixture was incubated at 30°C for 20 min, followed by quenching briefly on ice. DNA to which protein was bound was resolved from free DNA by electrophoresis through a 5% nondenaturing polyacrylamide gel (30:0.8 acrylamide : bis-acrylamide), run at 15 mA at 4°C. Before the samples were loaded, the gel was prerun for at least 90 min, at 100 V and 4°C. After electrophoresis, gels were dried under vacuum and exposed to X-ray film for 6-12 hr, as indicated in the text.
Methylation interference analysis
Methylation interference was performed essentially as described (Ausubel et al. 1989) . DNA probes were methylated partially with 1 | JL1 of DMS for 5 min, room temperature. Binding reactions and electrophoresis were as described for the gel mobility-shift assay, except 8-10 reactions (20,000 cpm probe/ assay) were pooled to augment the signals. After electrophoresis, the DNA was located by autoradiography of the wet gel, and the bound and free probes were excised from the gel. DNA was recovered by electrophoresing onto DEAE NA45 paper as described above. Carrier tRNA (10 \Lg] was added, and the DNAs were ethanol precipitated and washed with 70% ethanol. Pellets were dissolved in 1 M piperidine and incubated for 30 min at 90-99°C. As a control, a portion of the original methylated DNA was also treated with piperidine to serve as a marker ladder. After removal of the piperidine by lyophilization, the samples were loaded on 8% polyacrylamide-45% urea gels, which were dried and autoradiographed.
